A health services company decide for an initial public offerings (IPO) to increase its investment. The company utilizes a new business model in order to minimize the waiting lists for organ transplants in developing economies. This model is the farming of body parts to feed into the organ supply chain.
Related Case Solutions & Analyses:
Responding to a Heated Classroom Discussion: Affirmative Action Example
Differences at Work: Alex (B)
In the Company of Spies: When Competitive Intelligence Gathering Becomes Industrial Espionage
Genzyme and the Research Ethics Questions Associated with Its NeuroCell-PD (TM) Trials
Confidentiality of Settlement Negotiations: Ethics & Law
Anheuser-Busch and Campbell Taggart (Abridged)
Davis Press and Meccan Madness
Allen Lane
Corporate Social Responsibility and Competitive Advantage
Tesco
